Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Disease × Bupivacaine × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 8 Breast Neoplasms 4 Agnosia 4 Pain 3 Lung Neoplasms 3 Thyroid Neoplasms 2 Pancreatic Neoplasms 2 Neoplasms 2 Hyperparathyroidism 2 Colorectal Neoplasms 2 Chronic Pain 2 Urinary Bladder Neoplasms 1 Thyroid Nodule 1 Supratentorial Neoplasms 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Neuroma 1 Myofibroma 1 Liver Neoplasms 1 Leiomyoma 1 Laparoscopic Surgery 1 Intestinal Perforation 1 Hyperthyroidism 1 Graves Disease 1 Goiter, Nodular 1 Goiter 1 Epilepsy 1 Disease 1 Colonic Neoplasms 1

Interventions

Blood Specimen Collection 5 Mammography 4 Tomography, X-Ray Computed 3 Surveys and Questionnaires 3 Colonoscopy 3 Biopsy 3 Preoperative Exercise 2 Positron Emission Tomography Computed Tomography 2 Methods 2 Magnetic Resonance Spectroscopy 2 Magnetic Resonance Imaging 2 Control Groups 2 Biopsy, Fine-Needle 2 Water 1 Urine Specimen Collection 1 Urination 1 Ultrasonography 1 Triamcinolone Acetonide 1 Transcatheter Aortic Valve Replacement 1 Thoracoscopy 1 Thoracic Surgical Procedures 1 Therapeutics 1 Standard of Care 1 Sensitivity Training Groups 1 Patient Positioning 1 Occult Blood 1 Nutritional Status 1 Nutrition Assessment 1 Needles 1 Music Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07254650 2025-11-28

CALMS-1

University of Texas Southwestern Medical Center

Phase NA Not yet recruiting

Agnosia, Disease, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡